Pharmaceutical

Daiichi Sankyo

$34.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-0.52%) Today
$0.00 (0.00%) As of 9:44 PM UTC after-hours

Why Robinhood?

You can buy or sell Daiichi Sankyo and other stocks, options, and ETFs commission-free!

About DSNKY

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan. DSNKY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com). The listed name for DSNKY is Daiichi Sankyo Co Limited Sponsored ADR (Japan).

CEO
Sunao Manabe
Employees
15,348
Headquarters
Tokyo, Tokyo
Founded
2005
Market Cap
73.72B
Price-Earnings Ratio
104.36
Dividend Yield
—
Average Volume
29.05K
High Today
$35.42
Low Today
$34.16
Open Price
$35.42
Volume
2.91K
52 Week High
$38.00
52 Week Low
$16.11

Collections

You May Also Like

BAF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure